We use cookies for a better user experience. Read our Privacy Policy

I Agree

Cardiovascular & Soft Tissue Repair Patch Market

Cardiovascular & Soft Tissue Repair Patch Market (Product: Synthetic Patch and Biologic Patch [Xenogeneic Patch and Allogeneic Patch]; Application: Cardiovascular Repair [Cardiac Reconstruction and Vascular Reconstruction] and Soft Tissue Repair [Abdominal Wall Reconstruction, Thoracic Wall Reconstruction, Dural Reconstruction, Hernia Repair, and Others]; and End User: Hospitals, Ambulatory Surgical Centers, and Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Progress in Tissue Engineering to Drive Global Market

The past couple of decades have witnessed significant progress in technology that has played a key role in improving the different cardiac treatments and patient outcomes. Advancements in biomedicine have led to an increase in the deployment of natural bio polyesters such as polyhydroxyalkanoates (PHA) for an array of applications. As PHAs are biodegradable, biocompatible, and non-toxic, they are used in multiple applications as biomaterials. PHAs are also used in the implantology space as valves and sutures in the tissue engineering field as substitutes for a bone graft and cardiovascular patches. The significant rise in the number of congenital & acquired cardiovascular and soft tissue anomalies, rising demand for biologics for hernia and other soft tissue repair, and rapid progress in biomaterial and tissue engineering are some of the major factors that are expected to drive the cardiovascular & soft tissue repair patch market during the forecast period (2019-2027).

Research and development activities in the cardiovascular & soft tissue repair patch market are on the rise as healthcare providers continue to find new materials that will improve the effectiveness of these patches. Growing adoption of cardiovascular & soft tissue repair patches particularly for cardiac tissue engineering is expected to be a major driver that is projected to steer the global cardiovascular & soft tissue repair patch market past the ~US$ 4.4 Bn mark by the end of 2027.

cardiovascular soft tissue repair patch market infographic

To know the scope of our report Get a Sample on Cardiovascular & Soft Tissue Repair Patch Market

Improvements in Bio-based Techniques to Treat Cardiac Regeneration Likely to Fuel Demand

Cardiovascular diseases are the leading causes of death worldwide and the numbers surge each year. Of all major cardiovascular diseases, the prevalence of myocardial infarction (MI) is the highest. Another major cardiovascular condition that is likely to be a burden on the global healthcare systems is heart failure wherein the heart loses its functional capabilities. While there is no concrete treatment for heart failure, research and development activities continue to open up new opportunities in this field.

Get a glimpse of the in-depth analysis through our Report Brochure

In the past couple of decades, tissue regeneration to enhance cardiac degeneration and mitigate heart failure has emerged as an ideal solution wherein cardiovascular & soft tissue repair patches made of biomaterials are used. Apart from tissue engineering, noteworthy advancements in regenerative medicine have also opened up new opportunities for stakeholders in the cardiovascular & soft tissue repair patch market. Over the past few years, participants of the cardiovascular & soft tissue repair patch market are focusing on the development of biomaterial-based strategies to overcome cardiac regeneration post-myocardial infarction. In the current scenario, the two major techniques deployed for tissue engineering include cardiac patches and in situ gelling systems. Cardiovascular & soft tissue repair patches consist of cells and bioactive molecules that aid in the therapeutic healing and repair of soft tissues. Despite emerging as one of the most reliable and effective tissue engineering techniques, cardiovascular & soft tissue repair patches have received flak, as they require invasive surgeries for implantation. In the past few years, in situ gel systems gaining popularity. However, it could dent the prospects of cardiovascular & soft tissue repair patches in the near future.

R&D Paves Way for New Cardiovascular & Soft Tissue Repair Patches

Research and development activities have been critical in the field of biomedicine and biomedical engineering. Witnessing the growing demand for efficient solutions to repair or heal the structural changes of the heart post-myocardial infarction treatment has encouraged research and development in the current cardiovascular & soft tissue repair patch market. While stem cell therapies have offered significant promise in providing assistance for cardiac repair, the low retention capacity of the transplanted stem cells poses a major hurdle. Various drawbacks of alternative techniques to aid cardiac repair have encouraged researchers to focus on the discovery of new solutions.

For instance, a group of researchers from the U.S. and South Korea designed a new stretchable cardiovascular & soft tissue repair patch made using a cell-derived extracellular matrix (ECM). According to the researchers, ECM can play an important role in enhancing the adhesion of stem cells and accelerate the recovery process. Investments in research and development activities are expected to grow at a steady pace in the coming years due to which, new therapeutic cardiovascular & soft tissue repair patches are being developed using new biomaterials.

cardiovascular soft tissue repair patch market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global cardiovascular & soft tissue repair patch market is expected to grow at an impressive CAGR of ~10% during the forecast period. The market growth can be attributed to a range of factors, including rise in the prevalence of congenital & acquired cardiovascular and soft tissue anomalies and ascending demand for biologics for hernia and a range of other soft tissue repair applications. Stakeholders in the current cardiovascular & soft tissue repair patch market should focus on research and development activities to develop new and effective therapeutic cardiac patches. In addition, developments in the biomaterial and tissue engineering space are further expected to boost the prospects of the market for cardiovascular & soft tissue repair patches.

Cardiovascular & Soft Tissue Repair Patch Market: Overview

  • According to Transparency Market Research’s latest market report on the global cardiovascular & soft tissue repair patch market for the historical period (2017–2018) and forecast period (2019–2027), increase in geriatric population and rise in prevalence of congenital & acquired cardiovascular and soft tissue anomalies are projected to boost the growth of the global cardiovascular & soft tissue repair patch market during the forecast period. Moreover, inclination toward minimally invasive procedures is anticipated to fuel the growth of the global cardiovascular & soft tissue repair patch market.
  • According to the report, the global cardiovascular & soft tissue repair patch market was valued at US$ 1.9 Bn in 2018 and is expected to expand at a CAGR of ~10% from 2019 to 2027

Rise in Prevalence of Congenital & Acquired Cardiovascular and Soft Tissue Anomalies: Key Drivers

  • The number of people with congenital heart defects is increasing across the globe due to changes in lifestyle, dietary habits, and physical inactivity. Rise in prevalence of congenital heart defects such as atrial septal defects and ventricular septal defects is likely to fuel the growth of the global cardiovascular & soft tissue repair patch market.
  • According to the Centers for Disease Control and Prevention, an estimated 1% (40,000) babies are born with congenital heart defect in the U.S. every year, and ventricular septal defect (VSD) is the most common heart defect
  • Rise in demand for biologics, owing to increase in soft tissue repair procedures is likely to propel the cardiovascular & soft tissue repair patch market. According to the U.S. Food and Drug Administration, over 1 million hernia repairs are performed in the U.S. each year.
  • Increase in incidence of abdominal and other types of hernia, surge in usage of biologic patches i.e., xenogeneic patch & allogeneic patch, and inclination toward minimally invasive procedures leading to rise in demand for biologic cardiovascular & soft tissue repair patch products

Increase in Geriatric Population

  • The geriatric population is at high risk of developing heart-related problems. Aging leads to accentuated adverse remodeling and increased dysfunction of cardiac mechanism. As the population continues to age, older patients are being referred for repair of acquired VSD. Hence, increase in the geriatric population is projected to accelerate the growth of the cardiovascular & soft tissue repair patch market during the forecast period.
  • According to the U.S. Department of Health & Human Product estimates, the U.S. will have about 72.1 million elderly people by 2030, which is more than twice the number in 2000
  • According to World Population Prospects: the 2019 Revision, the population aged 65 and above is increasing faster than all other age groups across the globe

Availability of Alternate Treatments and Complications Associated with Patches Restrain Global Market

  • Cardiovascular & soft tissue repair are common procedures performed across the world. Herniorrhaphy and hernioplasty are the alternative treatments for hernia repair.
  • Mesh for hernia repair and valve for cardiovascular repair are used significantly across the globe. Hence, alternative treatments are likely to hamper the growth of the cardiovascular & soft tissue repair market.
  • Adhesion, seroma, recurrence of soft tissue defects or hernia, allergic reactions, and hematomas are the complications associated with patches which restrict their usage. This factor hampers the growth of the global cardiovascular & soft tissue repair patch market.

Cardiovascular & Soft Tissue Repair Patch Market: Competition Landscape

  • This report profiles major players in the global cardiovascular & soft tissue repair patch market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global cardiovascular & soft tissue repair patch market is moderately fragmented, with presence of a small number of large players in international markets and large number of small players in regional markets. Top 4 to 5 players hold majority share of the global cardiovascular & soft tissue repair patch market. Prominent players operating in the global cardiovascular & soft tissue repair patch market include
    • W. L. Gore & Associates, Inc.
    • BD, Edwards Lifesciences Corporation
    • CryoLife, Inc.
    • Baxter
    • Johnson & Johnson (Medical Devices Business Services, Inc.)
    • Aesculap, Inc. (B. Braun company)
    • Nurami Medical Nanofiber Technology
    • Medtronic
    • FOC Medical S.A.
    • Medprin Regenerative Medical Technologies Co., Ltd.
    • CorMatrix, Inc.
    • Terumo Corporation
    • Lamed GmbH
    •  South America Implants S.A.

Cardiovascular & Soft Tissue Repair Patch Market: Key Developments

  • Leading players in the global cardiovascular & soft tissue repair patch market are engaged in the development and approval of new products, merger & acquisitions, and collaborations. Strategies adopted by key players are likely to boost the growth of the global cardiovascular & soft tissue repair patch market. Strategies adopted by the players in the global cardiovascular & soft tissue repair patch market are:
    • In December 2019, Baxter acquired Seprafilm to expand its advanced surgery portfolio
    • In June 2019, CorMatrix, Inc. announced the U.S. Food and Drug Administration approval for the Cor PATCH for pericardial tissue repair and support in adult patients
    • In September 2018, South America Implants S.A. entered into a distribution agreement with Minimal Medics Co. to expand internationally
    • In November 2016, W. L. Gore & Associates, Inc. joined with leaders across the vascular and endovascular community in honoring five North American physicians
  • The report on the global cardiovascular & soft tissue repair patch market discusses individual strategies, followed by company profiles of manufacturers of cardiovascular & soft tissue repair patches. The competitive landscape section is included in the cardiovascular & soft tissue repair patch market report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cardiovascular & soft tissue repair patch market.

Cardiovascular & Soft Tissue Repair Patch Market - Segmentation

Product

Synthetic Patch

Biologic Patch

  • Xenogeneic Patch
  • Allogeneic Patch

Application

Cardiovascular Repair

  • Cardiac Reconstruction
  • Vascular Reconstruction

Soft Tissue Repair

  • Abdominal Wall Reconstruction
  • Thoracic Wall Reconstruction
  • Dural Reconstruction
  • Hernia Repair
  • Others

End User

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Cardiovascular & Soft Tissue Repair Patch Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of cardiovascular & soft tissue repair patch market?

Cardiovascular & soft tissue repair patch market is expected to expand at a CAGR of ~10% from 2019 to 2027

What is the anticipated CAGR of the cardiovascular & soft tissue repair patch market in the forecast period?

Cardiovascular & soft tissue repair patch market to reach valuation of ~US$ 4.4 Bn by 2027

What are the key driving factors for the growth of the cardiovascular & soft tissue repair patch market?

Cardiovascular & soft tissue repair patch market is driven by rise in prevalence of congenital & acquired cardiovascular and soft tissue anomalies

Which is the rising prominent segment in the cardiovascular & soft tissue repair patch market?

The biologic patch segment accounted for major share of the global cardiovascular & soft tissue repair patch market

Who are the key players in the cardiovascular & soft tissue repair patch market?

Key players in the global cardiovascular & soft tissue repair patch market include W. L. Gore & Associates, Inc., BD, Edwards Lifesciences Corporation, CryoLife, Inc., Baxter Johnson & Johnson (Medical Devices Business Services, Inc.)

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiovascular & Soft Tissue Repair Patch Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, 2017–2027

5. Market Outlook

    5.1. Key Industry Events (product launch and approval, key merger & acquisition, etc.)

    5.2. Overview of Cardiovascular and Soft Tissue Repair Patch 

    5.3. Epidemiology of Cardiovascular Diseases, Soft Tissue Injury, Dural Injuries, Peripheral Injuries, by Region/Country 

6. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2027

        6.3.1. Synthetic Patch

        6.3.2. Biologic Patch 

            6.3.2.1. Xenogeneic Patch 

            6.3.2.2. Allogeneic Patch

    6.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Product 

7. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

        7.3.1. Cardiovascular Repair 

            7.3.1.1. Cardiac Reconstruction

            7.3.1.2. Vascular Reconstruction

        7.3.2. Soft Tissue Repair 

            7.3.2.1. Abdominal Wall Reconstruction

            7.3.2.2. Thoracic Wall Reconstruction

            7.3.2.3. Dural Reconstruction

            7.3.2.4. Hernia Repair 

            7.3.2.5. Others

    7.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Application

8. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by End-user 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

        8.3.1. Hospitals

        8.3.2. Ambulatory Surgical Centers

        8.3.3. Specialty Clinics

    8.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by End-user 

9. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Country/Region

10. North America Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027

        10.2.1. Synthetic Patch

        10.2.2. Biologic Patch 

            10.2.2.1. Xenogeneic Patch 

            10.2.2.2. Allogeneic Patch

    10.3. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

        10.3.1. Cardiovascular Repair 

            10.3.1.1. Cardiac Reconstruction

            10.3.1.2. Vascular Reconstruction

        10.3.2. Soft Tissue Repair 

            10.3.2.1. Abdominal Wall Reconstruction

            10.3.2.2. Thoracic Wall Reconstruction

            10.3.2.3. Dural Reconstruction

            10.3.2.4. Hernia Repair 

            10.3.2.5. Others

    10.4. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgical Centers

        10.4.3. Specialty Clinics

    10.5. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis 

        10.6.1. By Product 

        10.6.2. By Application

        10.6.3. By End-user 

        10.6.4. By Country

11. Europe Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027

        11.2.1. Synthetic Patch

        11.2.2. Biologic Patch 

            11.2.2.1. Xenogeneic Patch 

            11.2.2.2. Allogeneic Patch

    11.3. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

        11.3.1. Cardiovascular Repair 

            11.3.1.1. Cardiac Reconstruction

            11.3.1.2. Vascular Reconstruction

        11.3.2. Soft Tissue Repair 

            11.3.2.1. Abdominal Wall Reconstruction

            11.3.2.2. Thoracic Wall Reconstruction

            11.3.2.3. Dural Reconstruction

            11.3.2.4. Hernia Repair 

            11.3.2.5. Others

    11.4. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

        11.4.1. Hospitals

        11.4.2. Ambulatory Surgical Centers

        11.4.3. Specialty Clinics

    11.5. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis 

        11.6.1. By Product 

        11.6.2. By Application

        11.6.3. By End-user 

        11.6.4. By Country/Sub-region

12. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027

        12.2.1. Synthetic Patch

        12.2.2. Biologic Patch 

            12.2.2.1. Xenogeneic Patch 

            12.2.2.2. Allogeneic Patch

    12.3. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

        12.3.1. Cardiovascular Repair 

            12.3.1.1. Cardiac Reconstruction

            12.3.1.2. Vascular Reconstruction

        12.3.2. Soft Tissue Repair 

            12.3.2.1. Abdominal Wall Reconstruction

            12.3.2.2. Thoracic Wall Reconstruction

            12.3.2.3. Dural Reconstruction

            12.3.2.4. Hernia Repair 

            12.3.2.5. Others

    12.4. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

        12.4.1. Hospitals

        12.4.2. Ambulatory Surgical Centers

        12.4.3. Specialty Clinics

    12.5. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis 

        12.6.1. By Product 

        12.6.2. By Application

        12.6.3. By End-user 

        12.6.4. By Country/Sub-region

13. Latin America Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027

        13.2.1. Synthetic Patch

        13.2.2. Biologic Patch 

            13.2.2.1. Xenogeneic Patch 

            13.2.2.2. Allogeneic Patch

    13.3. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

        13.3.1. Cardiovascular Repair 

            13.3.1.1. Cardiac Reconstruction

            13.3.1.2. Vascular Reconstruction

        13.3.2. Soft Tissue Repair 

            13.3.2.1. Abdominal Wall Reconstruction

            13.3.2.2. Thoracic Wall Reconstruction

            13.3.2.3. Dural Reconstruction

            13.3.2.4. Hernia Repair 

            13.3.2.5. Others

    13.4. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgical Centers

        13.4.3. Specialty Clinics

    13.5. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis 

        13.6.1. By Product 

        13.6.2. By Application

        13.6.3. By End-user 

        13.6.4. By Country/Sub-region

14. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027

        14.2.1. Synthetic Patch

        14.2.2. Biologic Patch 

            14.2.2.1. Xenogeneic Patch 

            14.2.2.2. Allogeneic Patch

    14.3. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

        14.3.1. Cardiovascular Repair 

            14.3.1.1. Cardiac Reconstruction

            14.3.1.2. Vascular Reconstruction

        14.3.2. Soft Tissue Repair 

            14.3.2.1. Abdominal Wall Reconstruction

            14.3.2.2. Thoracic Wall Reconstruction

            14.3.2.3. Dural Reconstruction

            14.3.2.4. Hernia Repair 

            14.3.2.5. Others

    14.4. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

        14.4.1. Hospitals

        14.4.2. Ambulatory Surgical Centers

        14.4.3. Specialty Clinics

    14.5. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis 

        14.6.1. By Product 

        14.6.2. By Application

        14.6.3. By End-user 

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis/Ranking, by Company, 2018

    15.3. Company Profiles

        15.3.1. W. L. Gore & Associates, Inc. 

            15.3.1.1. Company Overview

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis

        15.3.2. BD

            15.3.2.1. Company Overview

            15.3.2.2. Company Financials

            15.3.2.3. Growth Strategies

            15.3.2.4. SWOT Analysis

        15.3.3. Edwards Lifesciences Corporation 

            15.3.3.1. Company Overview

            15.3.3.2. Company Financials

            15.3.3.3. Growth Strategies

            15.3.3.4. SWOT Analysis

        15.3.4. CryoLife, Inc.

            15.3.4.1. Company Overview

            15.3.4.2. Company Financials

            15.3.4.3. Growth Strategies

            15.3.4.4. SWOT Analysis

        15.3.5. Baxter International, Inc.

            15.3.5.1. Company Overview

            15.3.5.2. Company Financials

            15.3.5.3. Growth Strategies

            15.3.5.4. SWOT Analysis

        15.3.6. Johnson & Johnson (Medical Devices Business Services, Inc.) 

            15.3.6.1. Company Overview

            15.3.6.2. Company Financials

            15.3.6.3. Growth Strategies

            15.3.6.4. SWOT Analysis

        15.3.7. Aesculap, Inc. (a B. Braun company)

            15.3.7.1. Company Overview

            15.3.7.2. Company Financials

            15.3.7.3. Growth Strategies

            15.3.7.4. SWOT Analysis

        15.3.8. Nurami Medical Nanofiber Technology 

            15.3.8.1. Company Overview

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis

        15.3.9. Medtronic

            15.3.9.1. Company Overview

            15.3.9.2. Company Financials

            15.3.9.3. Growth Strategies

            15.3.9.4. SWOT Analysis

        15.3.10. FOC Medical S.A. 

            15.3.10.1. Company Overview

            15.3.10.2. Growth Strategies

            15.3.10.3. SWOT Analysis

        15.3.11. Medprin Regenerative Medical Technologies Co., Ltd.

            15.3.11.1. Company Overview

            15.3.11.2. Growth Strategies

            15.3.11.3. SWOT Analysis

        15.3.12. CorMatrix, Inc.

            15.3.12.1. Company Overview

            15.3.12.2. Growth Strategies

            15.3.12.3. SWOT Analysis

        15.3.13. Terumo Corporation 

            15.3.13.1. Company Overview

            15.3.13.2. Company Financials

            15.3.13.3. Growth Strategies

            15.3.13.4. SWOT Analysis

        15.3.14. Lamed GmbH 

            15.3.14.1. Company Overview

            15.3.14.2. Growth Strategies

            15.3.14.3. SWOT Analysis

        15.3.15. South America Implants S.A.

            15.3.15.1. Company Overview

            15.3.15.2. Growth Strategies

            15.3.15.3. SWOT Analysis

List of Tables

Table 01: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

Table 03: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 04: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

Table 05: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

Table 06: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 07: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 08: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 09: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

Table 10: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 11: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

Table 12: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

Table 13: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 14: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 15: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 16: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

Table 17: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 18: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

Table 19: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

Table 20: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 21: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 23: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

Table 24: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 25: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

Table 26: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

Table 27: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 28: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 29: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 30: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

Table 31: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 32: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

Table 33: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

Table 34: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 35: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 36: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 37: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

Table 38: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 39: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

Table 40: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

Table 41: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 42: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figures

Figure 01: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn), by Product, 2018

Figure 03: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018

Figure 04: Market Overview

Figure 05: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by Product, 2018

Figure 06: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by Application, 2018

Figure 07: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by End-user, 2018

Figure 08: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by Region, 2018

Figure 09: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 10: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

Figure 11: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Synthetic Patch, 2017–2027

Figure 12: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Biologic Patch, 2017–2027

Figure 13: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

Figure 14: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

Figure 15: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Cardiovascular Repair, 2017–2027

Figure 16: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Soft Tissue Repair, 2017–2027

Figure 17: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

Figure 18: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

Figure 19: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2017–2027

Figure 20: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Ambulatory Surgical Centers, 2017–2027

Figure 21: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Specialty Clinics, 2017–2027

Figure 22: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019–2027

Figure 23: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Region, 2018 and 2027

Figure 24: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Region, 2019–2027

Figure 25: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 26: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

Figure 27: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

Figure 28: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

Figure 29: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

Figure 30: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

Figure 31: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027

Figure 32: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country, 2018 and 2027

Figure 33: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country, 2019–2027

Figure 34: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 35: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

Figure 36: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

Figure 37: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

Figure 38: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

Figure 39: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

Figure 40: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027

Figure 41: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 42: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 43: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 44: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

Figure 45: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

Figure 46: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

Figure 47: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

Figure 48: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

Figure 49: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027

Figure 50: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 51: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 52: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 53: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

Figure 54: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

Figure 55: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

Figure 56: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

Figure 57: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

Figure 58: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027

Figure 59: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 60: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 61: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 62: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

Figure 63: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

Figure 64: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

Figure 65: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

Figure 66: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

Figure 67: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027

Figure 68: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 69: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 70: Market Position Analysis, 2018, by Tier and Size of the Company

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

336

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved